For both the fourth quarter and full year 2025, the increases in R&D expenses were primarily due to higher clinical trial and manufacturing costs associated with the development of soquelitinib as ...
According to the National Association of Unclaimed Property Administrators (NAUPA), there are billions of dollars of unclaimed funds or property held by financial institutions, businesses, and state ...